Cargando…
Studying the Expression Efficiencies of Human Clotting Factor IX Analogs, Rationally-designed for Hyper-glycosylation
Glyco-engineering has attracted lots of interest in studies dealing with the pharmacokinetics of therapeutic proteins. Based on our previous in-silico studies, two sites were selected in the N-terminal gamma-carboxy glutamic acid-rich (Gla) domain of the human clotting factor IX (hFIX) to add new N-...
Autores principales: | Ghasemi, Fahimeh, Khorramizadeh, M.Reza, Karkhane, Ali Asghar, Zomorodipour, Alireza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457720/ https://www.ncbi.nlm.nih.gov/pubmed/34567179 http://dx.doi.org/10.22037/ijpr.2020.112027.13503 |
Ejemplares similares
-
In silico and in vitro analysis of a rational mutation in gIII signal peptide and its effects on periplasmic expression of rhGH in E. coli
por: Ghasemi, Fahimeh, et al.
Publicado: (2022) -
Functions of the Heterologous Intron-Derived Fragments Intra and Extra Factor IX-cDNA Coding Region on the Human Factor IX Expression in HepG2 and Hek-293T Cells
por: Sam, Mohammad Reza, et al.
Publicado: (2018) -
Optimization of The Electroporation Conditions for
Transfection of Human Factor IX into The Goat Fetal
Fibroblasts
por: Amiri Yekta, Amir, et al.
Publicado: (2013) -
Rational engineering of xylanase hyper-producing system in Trichoderma reesei for efficient biomass degradation
por: Yan, Su, et al.
Publicado: (2021) -
Novel synthetic clot analogs for in-vitro stroke modelling
por: Guerreiro, Helena, et al.
Publicado: (2022)